Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,586 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07653984Recruiting
Study on immune diseases in women of childbearing age
This study follows women with certain immune disorders affecting the nervous system (like multiple sclerosis or myasthenia gravis) to understand how these conditions affect reproduction. Healthy women planning pregnancy are also included for comparison.
Guangzhou, GuangdongAges 20–55 - NCT07655024RecruitingPhase 2
TAIC plus FOLFOX for advanced stomach cancer
This trial tests a traditional Chinese medicine (TAIC) combined with chemotherapy (FOLFOX) for people with advanced stomach or gastroesophageal junction cancer that can't be removed with surgery. It aims to see if the combination can help shrink the tumor and improve survival.
BeijingAges 18 years+ - NCT07655037Recruiting
Exercise study for severe asthma
This study tests if a personalized exercise program can help adults with severe asthma who are starting a new biologic treatment. It aims to improve symptoms and quality of life.
HelsinkiAges 18 years+ - NCT07655115RecruitingPhase 3
Arbaclofen for Autism: Brain Wave Study
This study tests a medicine called arbaclofen to see how it affects brain waves in people with autism. It includes a brief double-blind crossover phase followed by a 10-week open-label treatment period.
ParisAges birth–64 years - NCT07655310Recruiting
Parent factors and CT use in kids with minor head injury
This study looks at how a parent's background and understanding of health information might affect whether a child with a minor head injury gets a CT scan. It aims to better understand these factors to improve care.
BursaAges Up to 17 years - NCT07655622RecruitingPhase 1/Phase 2
Vebreltinib and furmonertinib for advanced EGFR-mutant lung cancer with high PD-L1
This trial tests a combination of two targeted drugs, vebreltinib and furmonertinib, for people with advanced non-small cell lung cancer that has an EGFR mutation and high levels of a protein called PD-L1. It may be an option for those who have not yet had treatment for advanced disease.
Nanchang, JianxiAges 18–75 - NCT07656168Recruiting
Testing a new blood filter to improve quality of life in kidney failure
This trial tests whether adding a special filter called pHA130 to your regular dialysis treatments can better remove certain waste products from your blood and improve your quality of life. It's for people who have been on dialysis for at least 3 months and meet a few health requirements.
BeijingAges 18 years+ - NCT07656649Recruiting
Sip-til-Send: Clear liquids before surgery
This trial tests whether allowing patients to drink clear fluids (like water or juice) up until surgery starts is safe, instead of fasting for hours. It may help you feel more comfortable before your operation.
Bergen, VestlandAges 18 years+ - NCT07657130RecruitingPhase 2
Timing of ADC drug for advanced breast cancer
This trial is testing the best time to give an antibody-drug conjugate (ADC) to people with advanced breast cancer that is HER2-negative. It aims to find out if giving this treatment after first chemotherapy fails can help slow the cancer's growth.
Shenyang, LiaoningAges 18–75 - NCT07657325Recruiting
Toripalimab for high-risk kidney cancer that has been removed
This trial tests whether the drug toripalimab can prevent kidney cancer from coming back in people who have had their kidney and any visible metastases surgically removed. It focuses on patients with high-risk features or who had some metastatic spots taken out completely.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07657403Recruiting
Brain mapping guided tumor surgery trial
This trial uses a brain connectivity map to help surgeons remove brain tumors while protecting areas that control language, movement, and thinking. It may be an option for people whose tumors are near important brain networks.
BeijingAges Any age - NCT07657390RecruitingPhase 1/Phase 2
Acupoint plaster for moderate to severe cancer pain
This study tests a special pain-relief plaster placed on acupoints (body points used in acupuncture) to see if it can help people with moderate to severe cancer pain who are already taking pain medications. The goal is to find a gentler way to improve pain control.
BeijingAges 18 years+ - NCT07657546Recruiting
MCG for chest pain without severe blockages
This trial tests a new way to measure blood flow in the heart, called MCG, for people who have chest pain but no severe blockages in their arteries. If you have symptoms like angina and your tests show only mild narrowing, you may be able to join.
Jinan, ShandongAges 18 years+ - NCT07657845Recruiting
Long-term safety of a freezing nerve block before pectus surgery
This study checks the long-term safety of a procedure called cryoneurolysis, which uses cold to temporarily numb certain nerves before surgery to fix a sunken chest (pectus excavatum). It may be for people who already had this treatment.
Bergamo, BGAges 14 years+ - NCT07658066Recruiting
Football to reduce stigma toward mental illness in students
This study tests whether playing football (soccer) can help reduce stigma toward mental illness. It compares the effectiveness of actual interaction with people who have mental illness versus watching videos. If you are a healthy university student who can safely play football, you may be eligible.
Kaohsiung CityAges 18–30 - NCT07658170Recruiting
Fat graft with platelet-rich fibrin for breast reconstruction after lumpectomy
This trial tests using a patient's own fat plus a special blood product (platelet-rich fibrin) to rebuild the breast right after a lumpectomy for breast cancer. It may help improve healing and appearance for women with early-stage, hormone-sensitive breast cancer.
Saint PetersburgAges 18–69 - NCT07658755Recruiting
LiverSeek: Finding advanced liver scarring in MASLD
This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.
Madrid, MadridAges 50–75 - NCT07658833Recruiting
Combined therapy for large liver cancer with vein clot
This trial combines a targeted drug and immunotherapy with procedures that deliver cancer-killing beads or chemotherapy directly to your liver tumor. It is designed for people with large, inoperable liver cancer that has spread into the main vein leading to the heart.
Guangzhou, None SelectedAges 18–75 - NCT07659054Recruiting
Shoulder brace study for clavicle fractures or rotator cuff tears
This study tests how wearing a shoulder brace affects joint movement and coordination in people with clavicle fractures or severe rotator cuff tears, compared to healthy volunteers. It may help understand the best ways to immobilize the shoulder after injury.
Taipei, TaiwanAges 20–65 - NCT07660406RecruitingPhase 1/Phase 2
Keloid imaging study with 68Ga-RGD PET-CT
This trial uses a special PET-CT scan to see if a tracer called 68Ga-RGD can help diagnose keloids. It may help doctors better understand and identify these scars.
BeijingAges 18–80 - NCT07662317Recruiting
Heart surgery recovery registry study
This study collects information from people having heart surgery to help doctors learn more about recovery. If you are scheduled for surgery during the study period, you may be able to join.
Hangzhou, ZhejiangAges Any age - NCT07662330Recruiting
Spermidine for weight and cholesterol in overweight adults
This trial tests if a natural supplement called spermidine can help lower cholesterol and body weight in overweight people with high cholesterol. You cannot be on any cholesterol or diabetes medications.
Shanghai, Shanghai MunicipalityAges 18–60 - NCT07662369RecruitingPhase 1/Phase 2
A trial of special immune cells for viral infections after transplant
This trial tests whether specially prepared donor immune cells can fight stubborn viral infections that did not get better with standard treatment. It is for people who have had a stem cell transplant and are still struggling with viruses like CMV, EBV, or others.
Shanghai, SHAges Any age - NCT07662655RecruitingEarly Phase 1
PADN for pulmonary hypertension after mitral valve repair
This study tests a new procedure called pulmonary artery denervation (PADN) to lower high blood pressure in the lungs that persists after a mitral valve repair. It aims to see if this extra treatment improves symptoms and outcomes for people with this condition.
Xiamen, FujianAges 18–80
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,586 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.